Accelerated Hypofractionated Radiotherapy in the Era of Concurrent Temozolomide Chemotherapy in Elderly Patients with Glioblastoma Multiforme

Introduction Patients with glioblastoma multiforme (GBM) over age 65 represent nearly half of those diagnosed per annum. They have a different tumor markers profile, physiologic reserve, and a median survival as low as three to four months. An optimal treatment strategy in older GBM patients remains...

Descripción completa

Detalles Bibliográficos
Autores principales: Greer, Liana, Pannullo, Susan C., Smith, Andrew W, Taube, Shoshana, Yondorf, Menachem Z, Parashar, Bhupesh, Trichter, Samuel, Nedialkova, Lucy, Sabbas, Albert, Christos, Paul, Wernicke, A. Gabriella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2017
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524564/
https://www.ncbi.nlm.nih.gov/pubmed/28775928
http://dx.doi.org/10.7759/cureus.1388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524564/
https://www.ncbi.nlm.nih.gov/pubmed/28775928
http://dx.doi.org/10.7759/cureus.1388

Ejemplares similares